Skip to main content

EDITORIAL article

Front. Psychiatry
Sec. ADHD
Volume 15 - 2024 | doi: 10.3389/fpsyt.2024.1490699
This article is part of the Research Topic Insights In ADHD: 2023 View all 8 articles

Editorial: Insights in ADHD: 2023

Provisionally accepted
  • Department of Pharmaceutical Health Services Research School of Pharmacy, School of Pharmacy, University of Maryland, Baltimore, Baltimore, United States

The final, formatted version of the article will be published soon.

    Keywords: ADHD, Pediatrics and adults, clinical practice, Emotion dysregulation, Biological mechanism, Treatment, diagnosis

    Received: 03 Sep 2024; Accepted: 05 Sep 2024.

    Copyright: © 2024 DosReis. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Susan DosReis, Department of Pharmaceutical Health Services Research School of Pharmacy, School of Pharmacy, University of Maryland, Baltimore, Baltimore, 21201, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.